Bladder Cancer

Underutilization of Blue Light Cystoscopy for Bladder Cancer in the United States - Beyond the Abstract November 15, 2021

Utility of Stromal Tumor Infiltrating Lymphocyte Scoring (sTILs) for Risk Stratification of Patients with Muscle-Invasive Urothelial Bladder Cancer After Radical Cystectomy - Beyond the Abstract November 9, 2021

Role of Local Therapy in Clinical Node-Positive Bladder Cancer - Beyond the Abstract November 8, 2021

Association of Age with Response to Preoperative Chemotherapy in Patients with Muscle-Invasive Bladder Cancer - Beyond the Abstract November 2, 2021

Society for Immunotherapy of Cancer (SITC) Clinical Practice Guideline on Immunotherapy for the Treatment of Urothelial Cancer - Beyond the Abstract October 12, 2021

Vaginal Complications after Radical Cystectomy for Bladder Cancer: A Systematic Review - Beyond the Abstract October 11, 2021

Role of Ki-67, MRE11, and PD-L1 as Predictive Biomarkers for Recurrence Pattern in Muscle-invasive Bladder Cancer - Beyond the Abstract October 11, 2021

Urologists, You’ll Never Walk Alone! How Novel Immunotherapy and Modern Imaging May Change the Management of Non-Muscle-Invasive Bladder Cancer - Beyond the Abstract October 6, 2021

Evaluation of Bowel Function Following Radical Cystectomy and Urinary Diversion Using Two Validated Questionnaires: What Are the Effects on Quality of Life? - Beyond the Abstract August 17, 2021

TERT Promoter Mutations and Other Prognostic Factors in Patients with Advanced Urothelial Carcinoma Treated with an Immune Checkpoint Inhibitor - Beyond the Abstract August 13, 2021

Early Photodynamic Diagnosis Cystoscopy after BCG Induction for High-Risk Non-Muscle Invasive Bladder Cancer Significantly Increased the Detection of BCG Refractory Tumors - Beyond the Abstract August 10, 2021

Comparison of Oncologic Outcomes Following Open and Robotic-assisted Radical Cystectomy with both Extracorporeal and Intracorporeal Urinary Diversion - Beyond the Abstract August 6, 2021

A miRNA Signature Predicts Benefit from Addition of Hypoxia-Modifying Therapy to Radiation Treatment in Invasive Bladder Cancer - Beyond the Abstract July 29, 2021

Oncological Outcomes of High-Grade T1 Non-Muscle-Invasive Bladder Cancer Treatment in Octogenarians - Beyond the Abstract July 26, 2021

WANTED: The T-cells Responsible for Cancer Immunotherapy - Beyond the Abstract July 26, 2021

Active Surveillance for Non-Muscle Invasive Bladder Cancer: A Systematic Review and Pooled-Analysis - Beyond the Abstract July 22, 2021

Macro and Microeconomics of Blue Light Cystoscopy with CYSVIEW® in Non-Muscle Invasive Bladder Cancer - Beyond the Abstract July 19, 2021

Rapamycin Enhances BCG-Specific γδ T Cells During Intravesical BCG Therapy for Non-Muscle Invasive Bladder Cancer: A Randomized, Double-Blind Study - Beyond the Abstract July 13, 2021

Pulsed Lasers and Endocorporeal Laser Lithotripsy – Beyond the Abstract July 13, 2021

First Time Intravesically Administered Trifunctional Antibody Catumaxomab in Patients with Recurrent Non-Muscle Invasive Bladder Cancer – Beyond the Abstract July 1, 2021

Page 1 of 18

email news signup